Amirmoezz Y et al. found that blocking mTOR in oral cancer up-regulated the expression of several immune accessory and adhesion molecules on the cell surface, including CD40, CD83, PD-L1, PD-L2, MHC class I, p selectin and VCAM-145. This evidence concerns the gene PDCD1LG2 and lip and oral cavity carcinoma.